Announcement of $11.1 million funding for COYA 302, an immune-based ALS therapy. Phase 2 study in US and Canada to test nerve damage reduction over six months.

Follow ALS progress: https://bit.ly/4kqzuxt

An experimental therapy called COYA 302 is moving closer to large scale production while a Phase 2 trial continues to test its ability to slow ALS progression.

#ALSNewsToday #Bionews #ALS #ClinicalTrials #ImmuneResearch

✨ We’re excited to be at ImmuMon @monashuniversity.bsky.social today! Visit the @10xgenomics.bsky.social booth, proudly presented by Millennium Science, and discover how our technologies are empowering immune research.

#ImmuMon2025 #ImmuneResearch #10xGenomics

💡 From gut immunity to co-culture systems, this organoid-focused review series in CEI, led by Joana Neves, brings together foundational knowledge for immune cell research.

🔗 bit.ly/4jL01o3

#ImmuneResearch #Organoids #Immunology

Danke an alle Teilnehmer, Sprecher & Posterpräsentatoren beim gestrigen #TagderImmunforschung in Frankfurt! Trotz Herausforderungen inspirierende Diskussionen und spannende Präsentationen. Auf ein Wiedersehen! #FraunhoferCIMD #Summerschool #immuneresearch